A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Worries
Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to users administering products of uncertain source.
Several experts said the demand for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.
Service Reaction and Material Elimination
Based on the social media company, the service has removed violative content and prohibited related hashtags and query recommendations. The organization said it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at home.
Within minutes of joining one group, a seller shared contact information, where most purchases occur. The seller sent an guidebook and promised delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Item Details and Pricing
Inside these groups, messages show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service said it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly serious health risks”.
